11 reports of this reaction
2.5% of all ARTICAINE HYDROCHLORIDE AND EPINEPHRINE reports
#5 most reported adverse reaction
HYPOAESTHESIA is the #5 most commonly reported adverse reaction for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, manufactured by Benco Dental. There are 11 FDA adverse event reports linking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE to HYPOAESTHESIA. This represents approximately 2.5% of all 433 adverse event reports for this drug.
Patients taking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE who experience hypoaesthesia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOAESTHESIA is a less commonly reported adverse event for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, but still significant enough to appear in the safety profile.
In addition to hypoaesthesia, the following adverse reactions have been reported for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE:
The following drugs have also been linked to hypoaesthesia in FDA adverse event reports:
HYPOAESTHESIA has been reported as an adverse event in 11 FDA reports for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOAESTHESIA accounts for approximately 2.5% of all adverse event reports for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, making it a notable side effect.
If you experience hypoaesthesia while taking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.